The proposed tumorigenic contribution of S100B has been associated with its ability to attenuate the tumor-suppressive activity of p53 by inhibiting p53 phosphorylation and regulating cell proliferation and differentiation through increasing mitogenic kinase Ndr (80) and Akt (81) activity (78). The gene discussed is S100B; the disease is neoplasm.